Cataract DME - Peri vs. Intraop
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT03920878
- Phase
- PHASE2
- Status
- Withdrawn
Conditions
- Cataract
- Diabetic Macular Edema
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Aflibercept injected Pre- and Post-operatively — DRUGThree injections of aflibercept before cataract surgery, and aflibercept injections after surgery within 14-21 days of the day of surgery (number of injections depends on clinical exam findings, visual acuity and retinal thickness).
- Aflibercept injected intraoperatively — DRUGThree injections of aflibercept before surgery and one injection of aflibercept during the course of the surgery by cataract surgeon.
Study Details
Goals of the study are to evaluate how peri-operative versus intra-operative anti-VEGF intravitreous injections affect visual acuity (BCVA) in patients with persistent diabetic macular edema who are undergoing cataract surgery; and to evaluate how peri-operative versus intra-operative anti-VEGF intravitreous injections affect OCT CSF thickness and total number of postoperative injections in patients with diabetic macular edema who are undergoing cataract surgery.
Key Dates
- Start date
- May 31, 2020
- Status verified
- Dec 2020
- Primary completion
- Jun 30, 2020
- Completion
- Jun 30, 2020
Study Design
- Enrollment
- 0 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Aflibercept injected Pre- and Post-operativelyPre- and Post-operative time of Aflibercept injections
- Active Comparator: Aflibercept injected intraoperativelyIntraoperative time of Aflibercept injection
Primary Outcome Measure
Change in best-corrected visual acuity (BCVA) [ Time Frame: 1 month, 3 months and 6 months after cataract surgery ]
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory Clinic | Atlanta | Georgia | 30322 | - |
| Grady Health System | Atlanta | Georgia | 30322 | - |
Find similar trials in Atlanta, GA
By condition
By specialty
By research site
Related Studies
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DMEPHASE3 · Recruiting · EyePoint Pharmaceuticals, Inc. · Bakersfield, California
- Intraocular Lens Power Calculation After Laser Refractive Surgery Based on Optical Coherence TomographyRecruiting · Oregon Health and Science University · Portland, Oregon
- Intraoperative OCT Guidance of Intraocular Surgery IIRecruiting · Duke University · Durham, North Carolina
- Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital PopulationPHASE4 · Recruiting · University of California, San Francisco · San Francisco, California